Watch the experts discuss additional SKYRIZI study results:
Dr. Richard Warren, an expert dermatologist, discusses data from the IMMerge PsO study.
Professors Strober and Van de Kerkhof, two expert dermatologists, discuss the IMMhance PsO trial.
Professor Kim Papp, principal investigator of KEEPsAKE-1 and -2, summarizes the results of the Phase 3 PsA studies.
You may also be interested in
Find out more about SKYRIZI
Reference
- SKYRIZI [Summary of Product Characteristics]. AbbVie Ltd; November 2021.